Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mangosteen-derived Mangostin as a Topical Prophylaxis Against Catheter-related Infections
TCTR20250326007Phase 2Completed
- Sponsor
- Phramongkutklao Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-Mangostin in catheter infection, sponsored by Phramongkutklao Hospital. Started Jul 2024; status: completed.
02
Drugs
alpha-Mangostin
03
Conditions
catheter infection
Beyond the preview
Go deeper on TCTR20250326007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250326007.